aTyr Pharma, Inc.ATYRNASDAQ
Loading
Year-over-year total asset growth rate
Latest
-11.71%
↓ 684% vs avg
Percentile
P28
Within normal range
Streak
1 qtr
Consecutive declineDecelerating
Average
2.01%
Historical baseline
| Period | Value |
|---|---|
| Q4 2025 | -11.71% |
| Q3 2025 | 5.04% |
| Q2 2025 | 4.41% |
| Q1 2025 | 0.43% |
| Q4 2024 | 5.69% |
| Q3 2024 | -13.52% |
| Q2 2024 | -6.46% |
| Q1 2024 | -6.13% |
| Q4 2023 | -3.53% |
| Q3 2023 | -5.78% |
| Q2 2023 | -2.99% |
| Q1 2023 | 42.86% |
| Q4 2022 | -0.28% |
| Q3 2022 | 0.04% |
| Q2 2022 | -8.36% |
| Q1 2022 | -9.31% |
| Q4 2021 | -6.76% |
| Q3 2021 | 152.92% |
| Q2 2021 | -11.13% |
| Q1 2021 | 42.35% |
| Q4 2020 | -6.99% |
| Q3 2020 | -12.46% |
| Q2 2020 | -12.65% |
| Q1 2020 | 50.46% |
| Q4 2019 | -17.28% |
| Q3 2019 | -10.29% |
| Q2 2019 | -2.31% |
| Q1 2019 | -5.37% |
| Q4 2018 | -11.76% |
| Q3 2018 | -12.49% |
| Q2 2018 | -12.95% |
| Q1 2018 | -12.18% |
| Q4 2017 | -5.43% |
| Q3 2017 | 53.71% |
| Q2 2017 | -6.49% |
| Q1 2017 | -18.37% |
| Q4 2016 | -6.29% |
| Q3 2016 | -14.49% |
| Q2 2016 | -12.72% |
| Q1 2016 | -11.22% |